Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly vs Treat and Extend Ranibizumab for Diabetic Macular Edema
NCT01476449Phase 2Completed
- Sponsor
- Retina Vitreous Associates of Florida
- Start
- Nov 2011
- Primary completion
- Sep 2016
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Retina Vitreous Associates of Florida. Started Nov 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01476449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01476449.